ANNX Stock Price Quote | Morningstar

Jan 9, 2025 · See the latest Annexon Inc Ordinary Shares stock price (ANNX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

12%
OFF

Annexon, Inc. (ANNX) Stock Price, Quote & News - Stock Analysis

2 weeks from now

6 days ago · Analyst Forecast. According to 7 analysts, the average rating for ANNX stock is "Strong Buy." The 12-month stock price forecast is $15.8, which is an increase of 227.12% …

stockanalysis.com

97%
OFF

SWYNX – Schwab Target 2060 Index – ETF Stock Quote

2 weeks from now

Feb 1, 2024 · A straightforward glide path delivers vintages in five-year increments from 2065 through 2010. Starting with 97% equity exposure, the weighting drops 20 percentage points …

morningstar.com

$250
OFF

American Funds Growth Fund Of Amer R6 RGAGX - Morningstar

2 weeks from now

Feb 20, 2024 · A combination of firm veterans and undisclosed managers oversee this fund’s roughly $250 billion asset base, the large-growth Morningstar Category’s biggest. After a …

morningstar.com

FAQs about ANNX Stock Price Quote | Morningstar Coupon?

What is annx Annexon stock price?

ANNX Annexon, Inc. Stock Price & Overview Follow $7.40-0.04(-0.54%)4:00 PM 10/25/24 NASDAQ |$USD |Post-Market:$7.55+0.15(+2.02%)6:22 PM Summary Ratings Financials Earnings Dividends Valuation Growth Profitability Momentum Peers Options Charting All Analysis Comments News SEC Filings Press Releases Related Analysis ANNX Stock Price 1D 5D 1M 6M ...

How much did Annexon (annx) earnings beat analysts' estimate?

In the previous quarter, Annexon (NASDAQ:ANNX) reported ($0.36) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.09. Learn more on analysts' earnings estimate vs. ANNX's actual earnings. How much profit does Annexon generate each year? Annexon (NASDAQ:ANNX) has a recorded net income of -$134.24 million. ...

Is Annexon (annx) a good stock to buy?

ANNX is trading within a range we consider fairly valued. Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. ...

Is Annexon listed on NASDAQ?

The company has applied to list on Nasdaq, under the ticker "ANNX." JP Morgan, BofA ... Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. ...

How much will Annexon earn per share?

The reported ($0.36) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.45) by $0.09. Annexon has generated ($1.78) earnings per share over the last year ( ($1.78) diluted earnings per share). Earnings for Annexon are expected to grow in the coming year, from ($1.36) to ($1.33) per share. ...

How much will Annexon Biosciences stock cost?

The company is now planning to offer 12.5 million shares priced at $15 to $16 each, according to a regulatory filin... Annexon Biosciences set terms for its initial public offering on Monday, with plans to offer 10 million shares priced at $14 to $16 each. ...